Trials / Completed
CompletedNCT01495390
A Longitudinal Study of Amyotrophic Lateral Sclerosis (ALS) Biomarkers
A Multicenter Study for the Discovery and Validation of ALS Biomarkers
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 139 (actual)
- Sponsor
- Massachusetts General Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to collect biofluid samples for the banking and usage in ALS research. Through comparison of these samples, the researchers hope to learn more about the underlying cause of ALS, as well as find unique biological markers, which could be used to develop new therapies.
Detailed description
The purpose of the research study is to collect blood samples and cerebrospinal fluid (CSF) from people with amyotrophic lateral sclerosis (ALS). These samples will be collected approximately every 4 months.
Conditions
- Amyotrophic Lateral Sclerosis
- Nervous System Diseases
- Sclerosis
- Motor Neuron Disease
- Spinal Cord Diseases
- Central Nervous System Diseases
- Neurodegenerative Diseases
- Neuromuscular Diseases
- ALS
Timeline
- Start date
- 2011-11-01
- Primary completion
- 2016-12-31
- Completion
- 2016-12-31
- First posted
- 2011-12-20
- Last updated
- 2017-05-30
Locations
6 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01495390. Inclusion in this directory is not an endorsement.